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Two of the critical challenges in the prognosis and treatment of cancer are early 
detection and targeted therapy of cancer. Imaging techniques such as MRI, X-ray CT, 
Ultrasound and Optical imaging are some of the non-invasive diagnostic tools available for 
this purpose. Every imaging method relies on the contrast of one particular (magnetic, 
electronic, acoustic and optical) property of the cancer cell against its surrounding medium of 
healthy cells. The sensitivity of the imaging technique limits the detection of small cancers or 
tumors owing to their sizes. The sensitivity can be enhanced by the use of appropriate 
contrast agents, particularly when they are tagged with a cancer targeting molecule for site 
specific delivery. In the present work, we have designed and developed biocompatible gold 
nanoparticles that are in vitro stable and are shown to localize in target organs of swine 
models. Furthermore, gold nanoparticles are tagged with bombesin, a cancer-seeking 
molecule, and are shown to have an excellent affinity towards cancer cells. Additionally, the 
effectiveness of cancer treatments such as radiotherapy and photothermal therapy can be 
significantly improved by presence of metallic nanoparticles that efficiently absorb radiation 
and help kill cancerous tissue. The degree of contrast enhancement in cancer imaging or 
effectiveness of cancer treatments is limited by the number of nanoparticles that can be 
localized at the target tumor/cancer site. One way to augment this localization is to utilize 
gold nanochains that hold a larger number of nanoparticles. Therefore, we developed 
biocompatible gold nanochains through self assembly of nanoparticles on gum arabic, which 
we have shown to be in vitro stable. The site specific gold nanoparticles developed can 
serve the dual purpose of contrast enhancement in cancer diagnosis and dosage increment 
in cancer therapy. 
Defective genes are believed to be the cause of cancer and tumors. One of the 
powerful tools in the identification of these defective genes is Surface Enhanced Raman 
Scattering (SERS). SERS is a spectroscopic method where the Raman scattering signal, 
which is sensitive to the molecular structure, is enhanced in the presence of gold 
nanoparticles. The slightly different structure of the defective genes manifests in distinct 
signatures in the Raman signal. Consequently, there is a need for nanostructures that 
enhance SERS signal. In the present project, gold nanoparticles set in agarose gel have 
been demonstrated to be excellent SERS substrates compared to commercially available 
gold nanoparticles for DNA nucleosides. The availability of these nanoparticles will give an 
impetus to the research and development of SERS based biosensors to detect carcinogenic 
agents, viruses, harmful and chemical agents. 
